NCT02386800 2026-03-16CINC424A2X01B Rollover ProtocolNovartisPhase 4 Active not recruiting279 enrolled
NCT05736419 2026-03-05A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)Memorial Sloan Kettering Cancer CenterPhase 2 Recruiting24 enrolled
NCT01881334 2025-11-20Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood TransplantsDuke UniversityAvailable
NCT03333486 2025-07-04Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood CancerRoswell Park Cancer InstitutePhase 2 Terminated31 enrolled 18 charts